BIO-RAD LABORATORIES, INC. (BIO) Income Tax Expense (Benefit) USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2024.
  • Bio Rad Laboratories, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $107 M, a 575% increase year-over-year.
  • Bio Rad Laboratories, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$121 M, a 102% decline year-over-year.
  • Bio Rad Laboratories, Inc. annual Income Tax Expense (Benefit) for 2023 was -$213 M, a 80.2% increase from 2022.
  • Bio Rad Laboratories, Inc. annual Income Tax Expense (Benefit) for 2022 was -$1.08 B, a 190% decline from 2021.
  • Bio Rad Laboratories, Inc. annual Income Tax Expense (Benefit) for 2021 was $1.19 B, a 8.25% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$121 M $107 M +$91.3 M +575% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 -$213 M $78.7 M -$185 M -70.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-16
Q3 2023 -$27.9 M $30.8 M +$75.4 M Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-27
Q2 2023 -$103 M -$338 M -$43.1 M -14.6% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-04
Q1 2023 -$60.2 M $15.9 M +$1.02 B Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 -$1.08 B $264 M +$725 M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-16
Q3 2022 -$1.8 B -$44.5 M -$1.14 B -104% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-27
Q2 2022 -$663 M -$295 M -$538 M -222% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 -$126 M -$1 B -$1.32 B -413% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $1.19 B -$462 M -$704 M -291% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-16
Q3 2021 $1.9 B $1.09 B +$725 M +196% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $1.17 B $243 M -$36.9 M -13.2% Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-29
Q1 2021 $1.21 B $320 M +$107 M +50.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $1.1 B $242 M +$95.9 M +65.7% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-17
Q3 2020 $1.01 B $370 M +$446 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $562 M $280 M +$109 M +63.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $453 M $213 M -$49.3 M -18.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $502 M $146 M +$359 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-11
Q3 2019 $144 M -$76.4 M -$157 M -195% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 $301 M $171 M +$98.7 M +137% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-31
Q1 2019 $202 M $262 M +$55.2 M +26.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $147 M -$213 M -$176 M -478% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-16
Q3 2018 $323 M $80.8 M +$72.3 M +848% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-01
Q2 2018 $251 M $72 M +$76 M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-06
Q1 2018 $175 M $207 M +$199 M +2575% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$24.5 M -$36.8 M -$27.3 M -287% Oct 1, 2017 Dec 31, 2017 10-K 2018-04-16
Q3 2017 $2.84 M $8.52 M +$2.92 M +52.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-05
Q2 2017 -$81 K -$3.92 M -$14.2 M -138% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $14.1 M $7.73 M -$1.47 M -15.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $15.6 M -$9.5 M -$18.1 M -211% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-16
Q3 2016 $33.7 M $5.6 M -$2.45 M -30.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-04-16
Q2 2016 $36.1 M $10.3 M -$817 K -7.35% Apr 1, 2016 Jun 30, 2016 10-K 2018-04-16
Q1 2016 $36.9 M $9.2 M +$324 K +3.65% Jan 1, 2016 Mar 31, 2016 10-K 2018-04-16
Q4 2015 $36.6 M $8.57 M +$1.86 M +27.7% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-16
Q3 2015 $34.7 M $8.05 M -$2.92 M -26.6% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 $37.7 M $11.1 M -$6.05 M -35.2% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $43.7 M $8.88 M +$1.01 M +12.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $42.7 M $6.71 M -$7.67 M -53.3% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-01
Q3 2014 $50.4 M $11 M +$9.08 M +482% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 $41.3 M $17.2 M +$2.72 M +18.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $38.6 M $7.87 M +$4 M +103% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 $34.6 M $14.4 M -$4.92 M -25.5% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $39.5 M $1.88 M -$10.5 M -84.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 $50 M $14.4 M -$3.01 M -17.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-06
Q1 2013 $53 M $3.88 M -$11.4 M -74.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 $64.4 M $19.3 M -$4.71 M -19.6% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $69.1 M $12.4 M +$2.47 M +24.9% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $66.6 M $17.5 M -$343 K -1.93% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 $66.9 M $15.2 M -$88 K -0.57% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 $67 M $24 M +$34.7 M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-18
Q3 2011 $32.3 M $9.91 M -$2.91 M -22.7% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 $35.2 M $17.8 M +$964 K +5.73% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 $34.2 M $15.3 M +$896 K +6.21% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q4 2010 $33.3 M -$10.7 M Oct 1, 2010 Dec 31, 2010 10-K 2013-03-18
Q3 2010 $12.8 M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $16.8 M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
Q1 2010 $14.4 M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.